Can I read Pcv41: Socioeconomic Relevance Of Treatment Of Chronic Heart Failure Stage Nyha Ii With Crataegus Extract Ws 1442—one-year-results Of A Prospective Pharmacoeconomic Study on EtoBox?

Pcv41: Socioeconomic Relevance Of Treatment Of Chronic Heart Failure Stage Nyha Ii With Crataegus Extract Ws 1442—one-year-results Of A Prospective Pharmacoeconomic Study by T Pfeil; R Rychlik; D Daniel; M Habs; HG Klapper; M Böhm is a Economics, Econometrics and Finance article available to read on EtoBox.

What is Pcv41: Socioeconomic Relevance Of Treatment Of Chronic Heart Failure Stage Nyha Ii With Crataegus Extract Ws 1442—one-year-results Of A Prospective Pharmacoeconomic Study about?

study of 100 adult asthmatics. RESULTS: The table reports outcomes over a 10-year period. Results were driven by the impact of ICS on quality of life, rather than on mortality. Findings were stable over most input data ranges. However, at efficacy levels below 3% and toxicity rates greater than 2.9%, the cost-effectiveness estimate exceeded $100,000/QALY. CONCLUSION: Results suggest that inhaled steroids deliver good comparative value in mild-to-moderate adult asthma. More research is needed, however, on the impact of ICS toxicity on patient preferences.

Who reads Pcv41: Socioeconomic Relevance Of Treatment Of Chronic Heart Failure Stage Nyha Ii With Crataegus Extract Ws 1442—one-year-results Of A Prospective Pharmacoeconomic Study?

Author

T Pfeil; R Rychlik; D Daniel; M Habs; HG Klapper; M Böhm

Publisher

John Wiley and Sons; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1098-3015)

Published

2001

Language

EN

Field

Economics, Econometrics and Finance (Social Sciences)